THIS natural supplement can prevent a transplant in heart failure cases
Researchers at Osaka University discovered that tricaprin, a natural supplement, significantly improves survival rates in patients with triglyceride deposit cardiomyovasculopathy (TGCV), a rare heart disease. The study revealed that tricaprin not only alleviated symptoms but also improved heart muscle function and reversed structural damage.
Cardiovascular diseases are the leading cause of death globally. These diseases claim an estimated 17.9 million lives each year, according to the World Health Organization (WHO).
In many extreme cases, such as
heart failure
, a transplant is the only option. Considering it is a serious surgery and comes at a high cost, it often puts the patients in great financial stress. However, researchers have now found that simply taking a
supplement
might be all that is needed for certain patients with heart failure to recover. Yes, that's right, no surgery required.
The researchers from Osaka University found that a
natural supplement
can significantly improve the survival in patients with a rare
heart disease
. The study, published in
Nature Cardiovascular Research
, found that
tricaprin
, a natural dietary supplement, can improve long-term survival and recovery from heart failure in patients with triglyceride deposit cardiomyovasculopathy (TGCV).
Operation Sindoor
Operation Sindoor: India deploys warships forward as situation at LoC explodes
Air siren warning sounded in Chandigarh, Ambala residents advised to stay indoors
L-70 guns, Schilka, S-400: Weapons India used to intercept Pak drones
What is TGCV?
Triglyceride deposit cardiomyovasculopathy (TGCV) is a rare cardiovascular disorder. This new type of
heart disease
is primarily reported in patients carrying certain genetic mutations. It results from an impaired ability of the heart and smooth muscle cells to break down triglycerides, which are a type of fat. Triglyceride accumulation in cells causes structural and functional damage in the heart and blood vessels. This leads to clogged arteries and weakened heart muscles, which may cause debilitating symptoms and eventually heart failure, which requires a
heart transplant
.
The tricaprin supplement, however, could be a breakthrough to treat this without a transplant.
Through a series of experiments, researchers have figured out how to diagnose the disease and developed a treatment that improves both disease symptoms and prognosis. 'Our previous research on the effect of tricaprin on patients with TGCV was very promising, but this time we decided to study how long the positive effects of the drug held up,' lead author of the study Ken-ichi Hirano said in a statement.
For this, the researchers analyzed data from 22 patients across 12 hospitals who were treated with tricaprin and compared them with 190 untreated patients. To ensure accuracy, 81 of the control patients were matched with the treated group based on similar health profiles.
Millena Brandão's Mystery Illness Turns Fatal; Child Star Dies After Multiple Heart Attacks
'Not only did the positive effects on patient symptoms continue, but the function of the heart muscle improved and the structural changes that had developed were reversed as well,' Ken-ichi Hirano, the principal investigator for the Japan TGCV study group, said.
All the patients initially had heart failure, but those treated with tricaprin had much better 3 and 5-year survival rates (both 100%) than the control group (78.6% and 68.1%). Several patients who had positive effects with tricaprin were on hemodialysis. These patients have a very poor prognosis without tricaprin.
'Spreading awareness of this disease to achieve early diagnosis and treatment offers patients the best chance for recovery,' Ken-ichi Hirano asserted.
The study is based on the data from Japanese patients, and the researchers are planning to carry it out in those from other ethnicities in the next step.
Masterclass for Students. Upskill Young Ones Today!– Join Now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Send beer samples every month for analysis: Delhi Excise dept to hotels, restaurants with microbreweries
The Excise Department in Delhi has directed hotels, cafes, and restaurants, which hold the L-11 licence, to share beer samples every month for analysis in the department's laboratory. The L-11 licence grants permission to hotels, cafes, and restaurants to set up microbrewery plants and sell them at their premises. At present, there are around half a dozen such plants in Delhi in Saket, Connaught Place, among other places. 'As per the terms and conditions of the L-11 license, the beer produced in the microbrewery shall be released for sale only after the said chemist certifies that such beer is fit for human consumption daily,' said the Excise Department in an official order, adding, 'Further, the licensee shall arrange to draw the beer samples once in every month and forward the same to the excise laboratory for analysis.' The department has also asked the licencees to display the report obtained from the excise laboratory on the premises of their microbrewery. 'Therefore, all L-11 licensees are hereby directed to adhere to the terms and conditions of L-11 licence strictly and obtain a certificate of their beer samples every month from the Excise laboratory for displaying the same at the premises of their microbrewery,' the order adds. The L-11 licencees have also been asked to send the certificate issued by the chemical examiner for each batch to the Excise Department.
Time of India
4 hours ago
- Time of India
The silent impact: How COVID-19 affected mental health globally
When the pandemic hit, the world focused on physical health; flattening the curve, increasing ICU beds, securing vaccines. But while the virus attacked lungs and immunity, it also quietly infiltrated our minds. The psychological toll of COVID-19 has been immense, yet much of it remains unseen, unspoken, and under-addressed. Each nation experienced its own kind of lockdowns, losses, and uncertainty. But across continents, there was one common thread: a silent mental health crisis playing itself out behind closed doors. The pressures of solitude, pain of loss, economic uncertainty, and fear of the unknown were a recipe for emotional stress. In countries like India, where extended family and social gatherings form the fabric of daily life, sudden isolation led to deep emotional disconnection. For many living in multi-generational homes, the fear of infecting vulnerable elders caused lingering anxiety. Elsewhere, in cities across Europe or North America, living alone became a double-edged sword, offering safety from the virus but amplifying loneliness. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Buy Durable Perforated Stainless Steel Sheets Online – Trusted Suppliers Stainless Steel Sheets | Search ADS Search Now Undo Anxiety, depression, insomnia, and burnout surged quietly, globally, and persistently. A 2022 WHO report estimated that the global prevalence of anxiety and depression increased by over 25% during the pandemic's first year alone. That number only begins to scratch the surface. Many who needed help didn't seek it. Some didn't recognize what they were feeling. Others feared the stigma. Mental health was tested not just by the virus, but by the silence around it. People grieved loved ones they couldn't say goodbye to, lost jobs they built their lives around, missed milestones they'd dreamed of. The parents overnight turned into teachers. Healthcare professionals strained themselves to the limit. Students lost the precious years of social development. The record continues. And yet, amid all this, we would constantly remind ourselves to be grateful. Grateful we lived. Grateful others were worse off. But gratitude and sorrow don't have to be mutually exclusive. You can be thankful and still wounded. That's what makes this emotional damage so confusing. For many, the pandemic didn't cause mental health struggles it magnified what was already there. Pre-existing anxiety worsened. Past trauma resurfaced. Coping mechanisms, like alcohol or overworking, quietly spiraled into addiction. Even those who appeared fine on the outside were often managing an invisible storm within. One of the hardest-hit groups? The youth. Teens and young adults who are already navigating identity, relationships, and career pressure, were suddenly cut off from the very social systems that helped them grow. Online classes, canceled exams, and uncertainty about the future created a unique kind of emotional whiplash. In India, mental health services were overwhelmed, especially in urban centers. But rural areas, where awareness and access were already limited, faced an even greater challenge. The digital divide became not just an educational issue, but a mental health barrier too. Here's how to address these things: First, we must acknowledge that healing from the pandemic isn't just about physical recovery but it's also emotional. We need global and local mental health systems that are responsive, affordable, and stigma-free. Governments, employers, schools, and families all have a role to play. Second, we must normalize asking for help. Therapy isn't a sign of weakness. It is a step toward understanding. Whether you're dealing with anxiety, fatigue, or just feeling 'off,' it matters. You matter. This approach goes beyond diagnosis we create compassionate, culturally aware support that helps people find their footing again. The pandemic may have been global, but healing starts one mind at a time. Whether you're still carrying the weight of those years or just beginning to unpack them, know this: you're not alone, and recovery is possible. (Dr. Tonmoy Sharma, Psychiatrist Founder and CEO, Merlin Health) One step to a healthier you—join Times Health+ Yoga and feel the change
The Hindu
7 hours ago
- The Hindu
Government plans to wind down National Polio Surveillance Network centres in India
The government has proposed to wind down, in phases, the World Health Organization (WHO)-established National Polio Surveillance Network (NPSN), currently a countrywide network of over 200 units. Experts in the field have commented that the move would be premature and ill-advised at this stage, with India's neighbouring countries still harbouring cases of polio. Staff at the NPSN centres have received a communication from the WHO's representative in India, Roderico H. Ofrin, advising them of an upcoming transition initiated by the government. The transition involves a gradual drawdown of the NPSN units each year — from approximately 280 units in 2024-25 down to 190 in 2025-26, and further to 140 in 2026-27. This is also linked with a corresponding reduction in financial support from the government, according to the communique. The process of transition will begin in June. 'We are not disbanding teams overnight or winding down the network haphazardly; rather, specific units will phase out at set intervals as government systems ramp up and absorb these functions,' Dr. Ofrin said. This will help us ensure that, at any given time, critical surveillance activities continue with minimal or no gaps, he said. While he assured the staff of the NPSN that this would help retain critical surveillance activities, at some point, polio surveillance would be subsumed within the Integrated Diseases Surveillance Programme. But the proposed winding down of a key unit, at a time when global resurgence of polio has been reported, has not gone down well, with either staffers or public health experts. India was declared polio-free in 2014, after three years of no case caused by wild polio virus transmission. The gains came after a full-frontal attack launched on polio, through years of coordinated work and oral polio immunisation campaigns, with a number of organisations collaborating. Jacob John, prominent virologist and vaccine expert, who has been actively involved in polio eradication efforts, including as a member on the National Technical Advisory Group on Immunisation, said he was 'horrified' by the move. 'The world has lots of polio still. It is way too early to upset our current 'steady state',' he added. He pointed out that Afghanistan and Pakistan continued to have polio cases, and that it is too close for comfort, also pointing to the danger of vaccine-derived polio virus. 'For every type 1 wild virus polio in Pakistan, there are about 10-12 circulating vaccine-derived poliovirus polio cases, mostly type 2, globally. After April 2016, we have not immunised children against type 2. In case vaccine derived polio virus is imported into India, widespread transmission and polio cases by the dozen are expected,' Dr. John said. A long-time campaigner for injectable polio vaccines (IPVs), Dr. John suggests that India should first replace oral polio vaccine (OPV) with IPV. After one year, all OPV can be withdrawn. Then, one year later, we can look at dismounting the watch. 'If surveillance is diluted now, we become sitting ducks for the resurgence of polio due to circulating VDPV, type 2 most likely, and type 1 less likely,' Dr. John said. Dr. Ofrin's letter also touches upon job security for existing staff, but the polio surveillance medical officers in the country under the Special Services Agreement, said it's not at all reassuring. 'Each centre has at least four employees. Imagine the number of people who won't have a job,' one doctor said, speaking on condition of anonymity. He also said that, since 2014, the NPSN had been functioning as a unit of the Central government, which expanded the role of the staff to conduct surveillance for measles and rubella, DPT (diphtheria, pertussis or whooping cough, and tetanus), child vaccination, and training the health workforce every time a new vaccine was introduced. He pointed out that there seemed to be no rationale in shutting down these particular centres. 'Vaccine-preventable diseases are a critical area; the country's progress should not be compromised at this stage,' he said.
